Etfidea LLC Trims Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Etfidea LLC cut its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.1% during the 4th quarter, Holdings Channel.com reports. The firm owned 24,406 shares of the financial services provider’s stock after selling 274 shares during the quarter. iShares Biotechnology ETF accounts for about 1.2% of Etfidea LLC’s holdings, making the stock its 22nd largest position. Etfidea LLC’s holdings in iShares Biotechnology ETF were worth $3,316,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of IBB. Activest Wealth Management purchased a new position in shares of iShares Biotechnology ETF during the 3rd quarter valued at $58,000. Householder Group Estate & Retirement Specialist LLC purchased a new position in shares of iShares Biotechnology ETF in the third quarter valued at about $60,000. HB Wealth Management LLC bought a new position in shares of iShares Biotechnology ETF in the third quarter worth about $219,000. Column Capital Advisors LLC purchased a new stake in shares of iShares Biotechnology ETF during the third quarter worth about $49,000. Finally, Premier Path Wealth Partners LLC bought a new stake in iShares Biotechnology ETF during the 4th quarter valued at approximately $207,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.3 %

IBB traded down $0.36 during trading on Wednesday, reaching $133.53. 1,116,780 shares of the company traded hands, compared to its average volume of 1,842,072. iShares Biotechnology ETF has a 12-month low of $111.83 and a 12-month high of $141.16. The firm has a fifty day simple moving average of $136.49 and a 200 day simple moving average of $129.02.

iShares Biotechnology ETF Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were issued a dividend of $0.126 per share. This represents a $0.50 annualized dividend and a dividend yield of 0.38%. The ex-dividend date of this dividend was Thursday, March 21st.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.